These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9413293)

  • 21. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cholangitis.
    To U; Silveira M
    Clin Liver Dis; 2018 Aug; 22(3):603-611. PubMed ID: 30259856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of long-term ursodiol treatment for patients with primary biliary cirrhosis.
    Jorgensen R; Angulo P; Dickson ER; Lindor KD
    Am J Gastroenterol; 2002 Oct; 97(10):2647-50. PubMed ID: 12385454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ursodeoxycholic acid story in primary biliary cirrhosis.
    Lim AG; Jazrawi RP; Northfield TC
    Gut; 1995 Sep; 37(3):301-4. PubMed ID: 7590420
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
    Combes B; Emerson SS; Flye NL; Munoz SJ; Luketic VA; Mayo MJ; McCashland TM; Zetterman RK; Peters MG; Di Bisceglie AM; Benner KG; Kowdley KV; Carithers RL; Rosoff L; Garcia-Tsao G; Boyer JL; Boyer TD; Martinez EJ; Bass NM; Lake JR; Barnes DS; Bonacini M; Lindsay KL; Mills AS; Markin RS; Rubin R; West AB; Wheeler DE; Contos MJ; Hofmann AF
    Hepatology; 2005 Nov; 42(5):1184-93. PubMed ID: 16250039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study.
    Larghi A; Crosignani A; Battezzati PM; De Valle G; Allocca M; Invernizzi P; Zuin M; Podda M
    Aliment Pharmacol Ther; 1997 Apr; 11(2):409-14. PubMed ID: 9146783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis.
    Heathcote EJ; Stone J; Cauch-Dudek K; Poupon R; Chazouilleres O; Lindor KD; Petz J; Dickson ER; Poupon RE
    Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ursodeoxycholic acid in primary biliary cirrhosis.
    Combes B
    Semin Liver Dis; 1997 May; 17(2):125-8. PubMed ID: 9170199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varices in early histological stage primary biliary cirrhosis.
    Ali AH; Sinakos E; Silveira MG; Jorgensen RA; Angulo P; Lindor KD
    J Clin Gastroenterol; 2011 Aug; 45(7):e66-71. PubMed ID: 20856137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary biliary cirrhosis and eosinophilia: regression after treatment with ursodeoxycholic acid].
    Irarreta A; Fernández J; Castiella A
    Gastroenterol Hepatol; 2006 Jan; 29(1):60-1. PubMed ID: 16393632
    [No Abstract]   [Full Text] [Related]  

  • 31. Ursodeoxycholic acid for primary biliary cirrhosis.
    Gong Y; Huang ZB; Christensen E; Gluud C
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000551. PubMed ID: 18677775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis.
    Pasha T; Heathcote J; Gabriel S; Cauch-Dudek K; Jorgensen R; Therneau T; Dickson ER; Lindor KD
    Hepatology; 1999 Jan; 29(1):21-6. PubMed ID: 9862844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advancing Second-Line Treatment for Primary Biliary Cholangitis.
    Assis DN
    N Engl J Med; 2024 Feb; 390(9):853-854. PubMed ID: 38381658
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
    Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
    Batts KP; Jorgensen RA; Dickson ER; Lindor KD
    Am J Gastroenterol; 1996 Nov; 91(11):2314-7. PubMed ID: 8931409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
    Lindor K
    N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
    [No Abstract]   [Full Text] [Related]  

  • 37. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
    Yan G; Erik C; Gluud C
    Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel Treatment Strategies for Primary Biliary Cholangitis.
    Parés A
    Semin Liver Dis; 2017 Feb; 37(1):60-72. PubMed ID: 28201850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
    Lammers WJ; Hirschfield GM; Corpechot C; Nevens F; Lindor KD; Janssen HL; Floreani A; Ponsioen CY; Mayo MJ; Invernizzi P; Battezzati PM; Parés A; Burroughs AK; Mason AL; Kowdley KV; Kumagi T; Harms MH; Trivedi PJ; Poupon R; Cheung A; Lleo A; Caballeria L; Hansen BE; van Buuren HR;
    Gastroenterology; 2015 Dec; 149(7):1804-1812.e4. PubMed ID: 26261009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment.
    Leuschner M; Dietrich CF; You T; Seidl C; Raedle J; Herrmann G; Ackermann H; Leuschner U
    Gut; 2000 Jan; 46(1):121-6. PubMed ID: 10601067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.